Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Jun 8;6(6):e0005875. doi: 10.1371/journal.pgph.0005875

Dynamical behavior analysis of 2-control strategies on tuberculosis model

M Abu Salek 1,2, Jannatun Nayeem 2,3,*, Muhammad Sajjad Hossain 3, M Humayun Kabir 1,2
Editor: Somayeh Hessam4
PMCID: PMC13245803  PMID: 42258452

Abstract

We develop and rigorously analyze a deterministic SEITR (Susceptible–Exposed–Infectious–Treated–Recovered) model that incorporates distancing and treatment interventions to examine the transmission dynamics of tuberculosis. The basic reproduction number (R0) is computed and decomposed to determine the threshold conditions for disease persistence. We propose a next-generation matrix formulation to determine the stability of the disease-free state and demonstrate that tuberculosis dies out whenever R0 < 1. Numerical implementation is performed using the fourth-order Runge–Kutta scheme and the backward sweep method, while Pontryagin’s maximum principle is utilized for determination of optimal intervention profiles. Sensitivity analysis is performed using normalized forward sensitivity indices, Pearson correlation, and Partial Rank Correlation Coefficient (PRCC). The results indicate that the transmission rate (β) is strongly positively correlated with the basic reproduction number (R0), whereas the control parameters (u1, u2) exhibit negative correlations with R0, highlighting their effectiveness in reducing disease transmission. The epidemiological efficacy of dual interventions is demonstrated by a significant decrease in infectious prevalence when both control measures are implemented simultaneously. Incremental cost-effectiveness ratio demonstrate that the combined control strategy is more cost-effective than individual interventions. These integrated analytical and numerical findings support the recommendation for sustained, early implementation of both distancing and treatment measures to achieve economically viable and dynamically stable tuberculosis mitigation.

1. Introduction

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (MTB), is a major global health issue that mainly affects the lungs [1]. While lung infections are most common, the bacteria can spread to other organs through the bloodstream, leading to extra-pulmonary TB, which is usually non-infectious [2,3]. Active TB shows symptoms like a long-lasting cough, chest pain, fever, weight loss, and night sweats. It spreads through airborne droplets. Healthcare professionals diagnose tuberculosis (TB) using skin tests (TST) for latent tuberculosis infection, not active disease. Diagnosis typically occurs a few weeks after exposure, even if symptoms may not develop until later. Researchers employ an SEITR compartmental model to comprehend the transmission of tuberculosis. This aids in the formulation of effective and efficient public health strategies [4,5]. Understanding how stable and sensitive a person is helps to decide where to put treatment and social distancing efforts. This can help communities control TB better in the long run [6,7]. A lot of the current TB models aren’t very accurate because they don’t take into account things like seasonal changes, social awareness, or the best ways to treat the disease [4,8]. Despite advances in chemotherapy and vaccination, sustained transmission persists due to delayed diagnosis, incomplete treatment adherence, close contact to infected individuals due to lack of precautions, and socioeconomic determinants. Mathematical modeling has therefore been extensively employed to understand TB transmission mechanisms and to evaluate the effectiveness of intervention strategies [9]. Compartmental epidemiological models such as SEIR, SEIRS, SEITR, and fractional-order TB models have been widely investigated in different previous studies [4,6,10–13]. Stability analyses have traditionally focused on determining the basic reproduction number R0, whose threshold behavior distinguishes disease elimination from persistence [14]. Optimal control strategies incorporating treatment, vaccination, awareness, and behavioral modifications have been studied using Pontryagin’s Maximum Principle (PMP) [15,16]. Optimal control theory is a useful tool for finding ways to reduce disease while making the best use of available resources [5,17]. This method is especially helpful for keeping TB under control in places as per rare health care resources. By systematically simulating disease progression under various conditions, we can pinpoint critical transmission drivers and assess the sensitivity of interventions. Mathematical modeling has also been useful for figuring out how effective and cost-effective TB control programs will be in the long run. Additionally, behavioral factors and longer treatment needs are included to improve realism and lower the chances of disease reactivation [7,18].

However, existing tuberculosis models have largely treated stability analysis, sensitivity analysis, and optimal control as separate components, which limits a full understanding of disease dynamics. In this study, we develop a unified SEITR model that integrates these elements within a single model, explicitly linking control-dependent stability analysis with sensitivity assessment to better capture tuberculosis transmission behavior [19,20]. The discussion is expanded to incorporate the epidemiological context of tuberculosis in Bangladesh, highlighting persistent transmission dynamics and associated public health challenges [21]. Furthermore, dominance relationships between competing control strategies, i.e., distancing versus treatment have not been rigorously decomposed at the level of threshold structure. Further studies have highlighted the need to combine vaccination, treatment, and preventive measures to meet bio-medical and economic goals [5,22].

The SEITR model is proposed by introducing clear exposed and treated compartments to better capture the progression of TB and its control dynamics, such as effects of vaccination and treatment on pandemic influenza in [23]. We integrate optimal control strategies to evaluate the performance of interventions in different epidemiological scenarios and to reduce the overall disease burden. Previous research has shown that TB elimination is possible when the basic reproduction number is below one; otherwise, persistence is expected [24,25]. It has been rarely analyzed the joint impact of distancing and treatment controls on tuberculosis transmission within a single mathematical model, leaving a gap in understanding their combined influence on disease dynamics. To address this limitation, a structured deterministic SEITR model is developed to examine tuberculosis transmission under these control measures and to provide quantitative insight relevant to public health decision-making. Through stability analysis, sensitivity evaluation by using forward sensitivity indices, Latin Hypercube Sampling, Pearson and Partial Rank Correlation Coefficients (PRCC), and the determination of key epidemiological thresholds, the study clarifies how these control strategies can influence the reduction of tuberculosis disease burden like as [26]. The proposed model adds to the existing literature by offering a structured mathematical basis for assessing effective and sustainable TB control strategies. The following are the key components of this study:

  • a. In what ways can stability analysis identify the threshold conditions that naturally suppress the spread of tuberculosis within a population?

  • b. When treatment and distancing techniques are adjusted, which epidemiological parameters have the most impact on the dynamics of tuberculosis?

  • c. How much can the prioritization of scarce public health resources in tuberculosis control programs be influenced by sensitivity analysis?

  • d. How can the SEITR optimum control model’s cost-effectiveness evidence help inform national tuberculosis policy decisions to priorities controls with the greatest public health impact within budget?

  • e. Is it possible for mathematically optimized control systems to achieve sustainable tuberculosis reduction more effectively than traditional intervention approaches?

The study demonstrates how these issues are resolved by a mathematically rigorous SEITR model that includes stability, sensitivity, and optimal control evaluations. The results are presented to facilitate evidence-based decision-making for effective and sustainable tuberculosis prevention.

The rest of this article is organized by the following sections: Section 2 outlines the construction of the controlling SEITR model, including its basic assumptions and mathematical structure; Section 3 describes the materials and methods used for doing analytical work; Section 4 looks into how stable the disease-free and endemic equilibria are; Section 5 establishes the objective functional and determines the optimal control conditions; Section 6 does the sensitivity analysis to find the important parameters. Numerical simulations and the implications of the results for epidemiology are presented in Section 7; Section 8 assesses the model validation using available data; Section 9 examines the cost-effectiveness of the proposed intervention options; and finally, a summary of the key findings and a direction for future research are mentioned in Section 10.

2. Model formulation

The SEITR model is a compartmental approach that shows susceptible (S) people who are healthy but at risk of getting TB, exposed (E) people who have been exposed to TB but are not yet infectious, infectious (I) people who have active TB and can spread the disease to others, treated (T) people who are getting treatment for TB, and recovered (R) people, as shown in Fig 1. We integrate control variables into the SEITR model to accommodate actual measures designed to reduce the transmission of tuberculosis (TB). Optimal control theory allows us to identify the most effective strategies for minimizing both the number of infectious individuals and the costs associated with these interventions. Here, we define two key control variables such as Distance Control (u1(t)) and Treatment Control (u2(t)) in this model as [27]. The non-linear differential equations, which reflect the dynamics between compartments of ordinary differential equations as in [28], are given below. The description of the model parameters is provided in S1 Appendix [29].

Fig 1. Diagram of TB transmission with control strategies.

Fig 1

The SEITR tuberculosis model with distancing control u1(t) and treatment control u2(t) has the following form

dSdt=Π−(1−u1(t))λS−μS,dEdt=(1−u1(t))λS−(κ+μ)E,dIdt=κE−(γ+u2(t)τ+μ+δ1)I,dTdt=u2(t)τI−(γ+μ+δ2)T,dRdt=γI+γT−μR,λ=βIN,N=S+E+I+T+R. (1)

Throughout the stability analysis, it is assumed that the controls are admissible, i.e.,

u1(t),u2(t)∈[0,1],for all t≥0,

and the solutions are uniformly bounded in the positively invariant region

Γ={(S,E,I,T,R)∈ℝ+5:N≤Πμ},

and continuously independent on the non-negative initial conditions S0≥0,E0≥0,I0≥0,T0≥0,R0≥0. Therefore, the model (1) is biologically well-proposed.

Here, u1(t) is the distancing control rate and the coefficient 1−u1(t) represents the prevention efforts to protect people in susceptible compartment from contacting infected individuals. And u2(t) represents the enhancement treatment effort for individuals in the infectious compartment.

3. Mathematical analysis

3.1. Positivity and boundedness of the model

The given model equations are

S˙=Π(1−u1)λS≥−((1−u1)λ+μ)S,⇒S(t)≥S(0)e−∫0t((1−u1)λ+μ)ds⇒S(t)>0,E˙=(1−u1)λS−k1E≥−k1E⇒E(t)≥E(0)e−k1t⇒E(t)≥0,I˙=κE−k2I≥−k2I⇒I(t)≥I(0)e−k2t⇒I(t)≥0,T˙=u2I−k3T≥−k3T⇒T(t)≥T(0)e−k3t⇒T(t)≥0,R˙=γI+γT−μR≥−μR⇒R(t)≥R(0)e−μt⇒R(t)≥0.

Since, N = S + E + I + T + R, then from (1) we have,

N˙=Π−μN−δI−δT≤Π−μN

Now,

N˙+μN≤Π⇒N(t)≤e−μtN(0)+Πμ(1−e−μt),Hence,lim supt→∞N(t)≤Πμ.

Theorem 1 The solution of the system is positively bounded for all (S(0),E(0),I(0),T(0),R(0))∈R+5 and also define for the positive value of time t.

3.2. Disease Free Equilibrium (DFE) and Basic Reproduction Number of the model

The model (1) exhibits a DFE, which is established by equating the right-hand sides of its equations to zero [30].

E0=(S,E,I,T,R)=(S*,0,0,0,0)=(Πμ,0,0,0,0) (2)

The stability of the DFE, E0 will be analyzed by next-generation method [31]. Presented below are the non-negative matrix P, which denotes the new infection terms, and V is the non-singular M-matrix, which relates to the remaining transfer terms.

P=[0(1−u1)βΠμ00000000000000],V=[k1000−κk2000−τu2k300−γ−γμ]

R0=ρ(PV−1), where ρ signifies the spectral radius (the largest eigenvalue in absolute value) of the next generation matrix PV−1. Consequently, it can be inferred that

R0=(1−u1)βΠκμk1k2

where, k1=κ+μ,k2=γ+u2τ+μ+δ1,k3=γ+μ+δ2.

3.3. Existence of the Endemic Equilibrium (EE)

Theorem 2 An endemic equilibrium E1 exists in Γ if and only if R0 > 1.

An endemic equilibrium E1=(S**,E**,I**,T**,R**) is defined by requiring I** > 0. At equilibrium, the following relations are obtained from (1).

From I˙=0,

κE**=(γ+u2τ+μ+δ1)I**⇒E**=γ+u2τ+μ+δ1κI**. (3)

From E˙=0,

(1−u1)λ**S**=(κ+μ)E**. (4)

Substituting (3) into (4) and using λ**=βI**/N** gives

(1−u1)βS**N**=(κ+μ)γ+u2τ+μ+δ1κ. (5)

Since 0<S**/N**<1, (5) implies that a strictly positive equilibrium requires

(1−u1)βκ>(κ+μ)(γ+u2τ+μ+δ1)⟺R0>1.

4. Stability analysis of the equilibria

4.1. Local stability of the DFE

Theorem 3 Let E0 denote the disease-free equilibrium of the system (1). Then E0 is locally asymptotically stable if R0 < 1, and unstable if R0 > 1.

To establish the local stability of DFE consider the infected subsystem (E,I), because new infections are generated through transitions into the exposed class via (1−u1)λS. The linearized infected subsystem around E0 is given by

(E˙I˙)=(−(κ+μ)(1−u1)βκ−(γ+u2τ+μ+δ1))(EI). (6)

The trace of the matrix in (6) is negative. The determinant is computed as

det=(κ+μ)(γ+u2τ+μ+δ1)−(1−u1)βκ. (7)

By rearranging (7), it is obtained that

det>0⟺(1−u1)βκ(κ+μ)(γ+u2τ+μ+δ1)<1⟺R0<1. (8)

Hence, the eigenvalues of (6) were shown to lie strictly in the left half-plane when R0 < 1, establishing local asymptotic stability.

4.2. Global Stability of the DFE

Theorem 4 The disease-free equilibrium E0 is globally asymptotically stable in the positively invariant region

Γ={(S,E,I,T,R)∈ℝ+5:N≤Πμ}

whenever R0 < 1.

To show global stability, the infected subsystem is bounded by a comparison system. Since S(t)≤N(t)≤Π/μ in Γ, it is obtained that

(1−u1)λS=(1−u1)βINS≤(1−u1)βI.

Hence the exposed equation satisfies

E˙≤(1−u1)βI−(κ+μ)E,

and the infected equation remains as

I˙=κE−(γ+u2τ+μ+δ1)I.

Thus, (E,I) is dominated by the linear comparison system

(E˙I˙)≤A(EI),A=(−(κ+μ)(1−u1)βκ−(γ+u2τ+μ+δ1)).

When R0 < 1, the matrix A is shown to be Hurwitz by (8), and therefore the comparison system decayed to zero. By the comparison principle, it is concluded that E(t)→0 and I(t)→0 as t→∞. Substituting into the remaining equations for T and R implies that T(t)→0 and R(t)→0, while S(t)→Π/μ.

4.3. Local stability of the Endemic Equilibrium (EE)

Theorem 5 The endemic equilibrium E1 is locally asymptotically stable whenever R0 > 1.

Local stability is established by the Jacobian evaluated at E1. Since the model is five-dimensional, here we consider only the infected subsystem (E,I).

Let x=(E,I)T. New infection terms appear only in the E-equation:

F(E,I)=((1−u1)βSIN0),V(E,I)=((κ+μ)E(γ+u2τ+μ+δ1)I−κE).

We linearize around the equilibrium and let us consider S** and N** are fixed.

Thus near E1, the infection term is approximated by

(1−u1)βSIN≈(1−u1)βS**N**I.

So the reduced Jacobian (infected block) is

JI(E1)=(−(κ+μ)(1−u1)βS**N**κ−(γ+u2τ+μ+δ1)).

The characteristic polynomial is

det(λI−JI)=|λ+κ+μ−(1−u1)βS**N**−κλ+γ+u2τ+μ+δ1|=(λ+κ+μ)(λ+γ+u2τ+μ+δ1)−κ(1−u1)βS**N**.

Hence

P(λ)=λ2+(κ+μ+γ+u2τ+μ+δ1)λ+((κ+μ)(γ+u2τ+μ+δ1)−κ(1−u1)βS**N**).

For a second-order polynomial

λ2+α1λ+α0,

local asymptotic stability is equivalent to:

α1>0,α0>0.

Here,

α1=κ+μ+γ+u2τ+μ+δ1>0automatically (all parameters positive).

Thus stability reduces to the sign of

α0=(κ+μ)(γ+u2τ+μ+δ1)−κ(1−u1)βS**N**.

Now from the endemic equilibrium derivation (5):

(1−u1)βS**N**=(κ+μ)γ+u2τ+μ+δ1κ.

Using the above condition into α0,

α0=(κ+μ)(γ+u2τ+μ+δ1)−κ(1−u1)βS**N**=(κ+μ)(γ+u2τ+μ+δ1)−(κ+μ)(γ+u2τ+μ+δ1)=0.

So at the endemic equilibrium, the reduced infected Jacobian has

P(λ)=λ2+(κ+μ+γ+u2τ+μ+δ1)λ.

Hence the eigenvalues are

λ1=0,λ2=−(κ+μ+γ+u2τ+μ+δ1)<0.

The characteristic polynomial of the infected subsystem satisfies the Routh-Hurwitz conditions when R0 > 1.Thus, the endemic equilibrium is locally asymptotically stable whenever it exists (i.e., for R0 > 1).

4.4. Global stability of the Endemic Equilibrium (EE)

Theorem 6 Assume that the controls are constants u1,u2∈[0,1] and that R0 > 1 so that the endemic equilibrium E1=(S**,E**,I**,T**,R**) exists with I** > 0. Then E1 is globally asymptotically stable in the positively invariant region Γ=ℝ+5.

Proof. Define the Lyapunov function on {S,E,I > 0}:

V(S,E,I)=(S−S**−S**lnSS**)+c1(E−E**−E**lnEE**)+c2(I−I**−I**lnII**),

where c1,c2>0 will be chosen. Since x−1−lnx≥0 for x > 0, it follows that V ≥ 0 and V = 0 if and only if S=S**, E=E**, and I = I**. Differentiating along solutions gives

V˙=(1−S**S)S˙+c1(1−E**E)E˙+c2(1−I**I)I˙.

Choose

c1=κκ+μ,c2=κγ+u2τ+μ+δ1.

Using the equilibrium identity Π=(1−u1)λ**S**+μS** and the relations (3)-(5), V˙ can be arranged as

V˙=−μ(S−S**)2S−(κ+μ)c1(E−E**)2E−(γ+u2τ+μ+δ1)c2(I−I**)2I+(1−u1)λ**S**Ξ,

where, after normalization

x=SS**,z=II**,w=NN**,

the remaining term takes the form

Ξ=3−1x−xzw−wz.

Let A=1x, B=xzw, and C=wz. These are positive and satisfy ABC = 1. Hence, by arithmetic mean (AM) and geometric mean (GM),

A+B+C3≥ABC3=1⇒A+B+C≥3⇒Ξ≤0.

Therefore V˙≤0 for all (S,E,I)∈ℝ+3. Moreover, V˙=0 holds only when S=S**, E=E**, I = I** and simultaneously A = B = C = 1, which yields N=N**. On this invariant set, the remaining linear subsystem

T˙+(γ+μ+δ2)T=u2τI,R˙+μR=γI+γT

implies T(t)→T** and R(t)→R**. By LaSalle’s invariance principle, every trajectory in Γ converges to E1. Thus E1 is globally asymptotically stable.

4.5. Absence of backward bifurcation

Lemma 1 Consider the SEITR system (1) with standard incidence λ=βI/N and constant controls u1,u2∈[0,1]. If R0=(1−u1)βκ(κ+μ)(γ+u2τ+μ+δ1).

Then the following statements hold:

  • (i) The disease-free equilibrium exists for all parameter values and is locally asymptotically stable whenever R0 < 1.

  • (ii) A strictly positive endemic equilibrium exists only when R0 > 1 and is unique in the feasible region.

Consequently, no endemic equilibrium can coexist with the disease-free equilibrium for R0 < 1, and therefore a backward bifurcation at R0 = 1 does not occur; the system undergoes a forward (transcritical) bifurcation at R0 = 1.

5. Objective functional of optimal control

The objective functional quantifies the trade-off between reducing the infectious population and minimizing intervention costs over a fixed time horizon. It is expressed as:

minJ(u1,u2)=∫0T[a1E+a2I+a3T+12(a4u12+a5u22)]dt.

where, a1, a2, a3, a4 and a5 are weight parameters and all are positive. The squared terms represent the cost of control measures, assuming they increase quadratically with their intensity.

5.1. Characterization of the optimal control

By Pontryagin’s Maximum Principle (PMP), which transforms the problem into a system of differential equations involving state variables S(t), E(t), I(t), T(t) and R(t) adjoint variables: ΛS,ΛE,ΛI,ΛT and ΛR and Hamiltonian. The Hamiltonian incorporates the objective function and state dynamics as:

H=a1E+a2I+a3T+a4u122+a5u222+ΛS[Π−(1−u1)λS−μS]+ΛE[(1−u1)ΛS−κE−μE]+ΛI[κE−γI−u2τI−μI−δ1I]+ΛT[u2τI−γT−μT−δ2T]+ΛR[γI+γT−μR]

where, ΛS,ΛE,ΛI,ΛT and ΛR are adjoint variables.

ΛS ′=(1−u1)λΛS+μΛS−(1−u1)λΛEΛE ′=−a1+κΛE+μΛE−κΛIΛI ′=−a2+γΛI+u2τΛI+μΛI+δ1ΛI−u2τΛT−γΛRΛT ′=−a3+γΛT+μΛT+δ2ΛT−γΛRΛR ′=μΛR

The adjoint variables Λi satisfying dΛidt=dHdt with the transversity conditions, Λi(T)=0, i = S, E, I, T, R.

The optimality condition is given by dHdui=0, i = 1, 2.

For the control u1 we have, Hu1|u1=u1*=0 ⟹a4u1*+λSΛS−λSΛE=0 ⟹u1*=βIS(ΛE−ΛS)a4 and, for the control u2 we can write, Hu2|u2=u2*=0 ⟹a5u2*+τIΛI+τIΛT=0

⟹u2*=τI(ΛI−ΛT)a5

So, we have the controls,

u1*=min(1,max(0,βIS(ΛE−ΛS)a4)) and u2*=min(1,max(0,τI(ΛI−ΛT)a5)).

6. Sensitivity analysis

Sensitivity analysis is a quantitative tool for determining how differences in model parameters affect the behaviour or consequences of a mathematical system. A global sensitivity analysis is performed using Latin Hypercube Sampling (LHS) combined with standardized regression coefficients (SRC), Pearson correlation coefficients, and Partial Rank Correlation Coefficients (PRCC)(S1 Fig). A total of N = 1000 parameter sets are generated within biologically feasible ranges. The basic reproduction number R0 is evaluated for each sampled set and statistical associations between parameters and R0 are quantified.

6.1. Analytical analysis of sensitive parameters

To analyze the sensitivity we defined an explicit formula for R0 as,

χrR0=(rR0)(∂R0∂r)

where, R0=R0(β,κ,γ,τ,δ1,u1,u2) and r represents a parameter. Certain key parameters of the model (1) have a significant impact on the basic reproduction number, R0. The numerical expressions for the respective parameters of the model are defined as follows:

∂R0∂β=Πκ(1−u1)μ(κ+μ)(γ+u2τ+μ+δ1)∂R0∂κ=βΠ(1−u1)μ(κ+μ)2∂R0∂γ=−βΠκ(1−u1)μ(κ+μ)(γ+u2τ+μ+δ1)2∂R0∂τ=−βΠκ(1−u1)u2μ(κ+μ)(γ+u2τ+μ+δ1)2∂R0∂δ1=−βΠκ(1−u1)μ(κ+μ)(γ+u2τ+μ+δ1)2∂R0∂u1=−βΠκμ(κ+μ)(γ+u2τ+μ+δ1)∂R0∂u2=−βΠκ(1−u1)τμ(κ+μ)(γ+u2τ+μ+δ1)2 (9)

Algorithm 1 Stepwise procedure for computing the optimal controls u1*(t) and u2*(t) in the controlled SEITR model

Input:  Model parameters Π,β,κ,γ,τ,μ,δ1,δ2; weights a1,a2,a3,a4,a5>0; time horizon [0,T]; initial states S(0),E(0),I(0),T(0),R(0); tolerance ε>0; maximum iterations M.

Output: Optimal control profiles u1*(t),u2*(t) and optimal state trajectories S*(t),E*(t),I*(t),T*(t),R*(t).

Step 1 (Initialize). Set an initial guess on [0,T], e.g., u1(0)(t)≡0, u2(0)(t)≡0, and set m = 0.

Step 2 (Forward state solve). With u1(m)(t) and u2(m)(t), solve the SEITR state system forward on [0,T] to obtain (S(m)(t),E(m)(t),I(m)(t),T(m)(t),R(m)(t)). Compute λ(m)(t)=βI(m)(t)N(m)(t), where N(m)(t)=S(m)(t)+E(m)(t)+I(m)(t)+T(m)(t)+R(m)(t).

Step 3 (Terminal conditions). Impose ΛS(T)=ΛE(T)=ΛI(T)=ΛT(T)=ΛR(T)=0.

Step 4 (Backward adjoint solve). Using the trajectories from Step 2, solve the adjoint system backward on [0,T]:

ΛS′(t)=(1−u1(m)(t))λ(m)(t)ΛS(t)+μΛS(t)−(1−u1(m)(t))λ(m)(t)ΛE(t), ΛE′(t)=−a1+(κ+μ)ΛE(t)−κΛI(t), ΛI′(t)=−a2+(γ+u2(m)(t)τ+μ+δ1)ΛI(t)−u2(m)(t)τΛT(t)−γΛR(t), ΛT′(t)=−a3+(γ+μ+δ2)ΛT(t)−γΛR(t), ΛR′(t)=μΛR(t).

Step 5 (Control update). Update pointwise and project onto [0,1]:

u1(m+1)(t)=min{1,max(0, βI(m)(t)S(m)(t)(ΛE(t)−ΛS(t))a4N(m)(t))},

u2(m+1)(t)=min{1,max(0, τI(m)(t)(ΛI(t)−ΛT(t))a5)}.

Step 6 (Convergence check). If ‖u1(m+1)−u1(m)‖∞+‖u2(m+1)−u2(m)‖∞<ε, stop and set ui*(t)=ui(m+1)(t) for i = 1,2.

Step 7 (Iterate). Otherwise set m←m+1; if m < M, return to Step 2, else stop and report the last iterate as the numerical approximation.

After analytic simplification considering (9), the results are summarized in S1 Table, using the above explicit derivative formula in relation to the model parameters, based on the values provided in S1 Appendix.

6.2. Statistical significance

The statistical significance of PRCC values was evaluated using the test statistic

t=rN−k−21−r2 (10)

with df=N−k−2 degrees of freedom. For N = 1000 and k = 6, df = 992. The factors u1, β, δ1, and γ are determined to be highly statistically significant (p < 0.001), suggesting that their effect on R0 is improbable to result from random sampling variability. The remaining parameters displayed weak correlations with relatively high p-values, indicating minimal statistical influence on R0 within the examined ranges. Due to PRCC values approaching ±0.95 with N = 1000 resulting in exceedingly huge t-statistics, the p-values are essentially < 0.001 (in fact, significantly less).

The scatter plots in Fig 2 (S1 Fig) show the correlations between each model parameter and the basic reproduction number R0, with Slope, Pearson, and PRCC values in each panel. Increased contact reduction significantly reduces transmission potential, as shown by a major negative influence on the distance control parameter u1 (Slope = -0.68674, Pearson = -0.69009, PRCC = -0.95354), with a 95% confidence interval (-0.95885, -0.94756). The transmission rate β is positively correlated with epidemic intensity (Slope = 0.58425, Pearson = 0.57036, PRCC = 0.93028, 95% confidence limits (0.92143, 0.93817), indicating extreme sensitivity to transmission efficiency variations. Shortening the infectious time has moderate negative impacts on the disease-induced death rate δ1 (PRCC = -0.66736) and recovery rate γ (PRCC = -0.59017), highlighting its epidemiological significance. The progression rate κ (PRCC = 0.023958), treatment rate τ (PRCC = -0.087536), and treatment control u2 (PRCC = -0.072582) have weak sensitivities, indicating limited impact in the examined parameter ranges. Slope and Pearson values are consistent, confirming linear trends, while PRCC magnitudes imply monotonic correlations after correcting for parameter interactions. The figure shows that contact reduction and transmission intensity dominate transmission dynamics, while treatment-related processes have a smaller impact on R0. The statistical significance and the sensitivity interpretation of R0 of the influential parameters of the model are described in the following S2 Table.

In this study, both Standardized regression coefficients (SRC) and Partial Rank Correlation Coefficient (PRCC) recognised u1 and β as dominating parameters; however, PRCC values had stronger magnitudes. This shows that monotonic correlations exist, and that PRCC provides a more reliable assessment of parameter influence in nonlinear epidemiological systems. As a result, PRCC is regarded as the most trustworthy sensitivity metric for assessing model behaviour.

Overall, the table shows that epidemic transmission is primarily governed by mechanisms controlling effective contact and transmission intensity, while removal and treatment processes have a secondary influence, and disease progression plays only a minor role in determining R0 within the specified parameter range. Finally, the Fig 2 depicts the impact of parameters, while the statistical formula (10) verifies the statistical significance of that impact.

Fig 2. Regression, Pearson and PRCC analysis of model parameters by scatter diagram.

Fig 2

Fig 3 shows the Partial Rank Correlation Coefficient (PRCC) values for various parameters impacting the five compartmental model with distance and treatment controls. The bar graphs illustrate the sensitivity of each compartment to changes in parameters such as transmission rate (β), progression rate (κ), recovery rate (γ), death rates (μ, δ1, δ2), control methods (u1, u2), and recruitment rate (Π). Parameters with bars close to 1 or -1 have the most impact. If the value is positive, increasing the parameter raises the number of members in that group. If the value is negative, reducing the parameter reduces the number.

Fig 3. PRCC indices of all parameters for each compartments of the model.

Fig 3

From an epidemiological approach, the PRCC analysis identifies the parameters with the most influence on the model’s compartments. A strong positive PRCC value for transmission rate β and progression rate κ in susceptible and exposed populations implies that these parameters significantly influence individuals’ transition into infection. Distancing control u1, treatment control u2, and disease-related death rates all have substantial negative relationships with the infected class, showing their effectiveness in reducing active infection. Treatment effort u2 and recovery rate γ have significant effects on treated and recovered compartments, highlighting the need of maximizing contact reduction, treatment efficiency, and recovery in tuberculosis control.

6.3. Sensitivity analysis of different parameters

The sensitivity analysis presented in the figures highlights the differential impact of varying parameters β, γ, and κ on the infectious population over 50 years.

In Fig 4 (S1 Fig), the parameter β (Fig 4A), likely representing the effective contact rate, exhibits a substantial increase in the infectious population with a + 10% elevation (dashed red line) relative to the baseline (solid black line). A −10% reduction (dotted blue line) demonstrates the opposite effect, indicating that the population is very responsive to fluctuations in transmission. In Fig 4B, the parameter γ illustrates the recovery rate; a + 10% rise (dashed red line) results in a reduction in the number of individuals who are ill, as a greater number of individuals recover. Conversely, a −10% reduction (dotted blue line) results in a significant rise in the number of individuals who are ill, highlighting the critical role of recovery in halting the transmission. In a similar way, for κ (Fig 4C), which presumably represents the transition rate from exposed to infectious, a + 10% increase (dashed red line) results in a heightened infectious population, whilst a −10% decrease (dotted blue line) yields a diminished one. Nonetheless, its effect is less significant than that of β or γ. These statistics indicate that the infectious population is highly responsive to variations in the effective contact rate (β) and recovery rate (γ), highlighting these parameters as essential targets for intervention efforts to manage the disease.

Fig 4. Sensitivity analysis impact on infectiousness for β, γ, and κ.

Fig 4

7. Model validation

The data on tuberculosis cases in Bangladesh shown in the picture are from the World Health Organization’s Global Tuberculosis Report database and the World Bank’s World Development Indicators repository [32] (S1 Data). For curve fitting and projection, a nonlinear polynomial regression method is used, and the least-squares optimization method is employed to obtain the model coefficients. The coefficient of determination (R²), which is greater than 0.97, is used to assess how well the fitted model performs. This means that the observed and modeled values are quite close.

In Fig 5 (S1 Fig), TB Case Projection with Fitted Curve (2010–2030) visually represents. In this figure, the green bars correspond to the observed TB case data from 2010 to 2025 [33], based on surveillance and reporting. The red bars project TB cases from 2026 to 2030 using the SEITR model, which incorporates disease progression and control strategies such as treatment and social distancing. A smooth blue curve has been fitted across the entire data set using nonlinear regression or similar techniques to capture the trend of infection spread over time.

Fig 5. Curve fitting of infected cases with model prediction with projection up to 2030.

Fig 5

The curve fitting serves as a validation tool to assess how accurately the SEITR model captures the real behavior of TB transmission dynamics. The fitted curve shows that the number of TB cases steadily rises until it reaches a peak around 2025, after which it slowly falls during the forecast period. This pattern demonstrates how actions modelled in the system, such as increasing treatment rates and behavioural modifications like distance, have an impact. The fact that the curve and the real data (green bars) are so similar during the years studied shows that the model is very stable, which means it will continue to be useful for tracking population-level TB changes over time. The model is also quite sensitive to control factors, as seen by the red bars showing a decrease in anticipated cases. This means that good treatment and distance can greatly lower the number of TB cases by 2030. This demonstrates that mathematical modelling not only improves understanding of disease patterns, but it also serves as a forecasting tool for policymakers.

Fig 6 (S1 Fig) illustrates how model-generated trends from 2010 to 2025 compare to reported TB cases (S1 Text). The red plus signs depict real TB case data from 2010 to 2025, which shows a steady growth from fewer than 100 cases to almost 1000. The orange line, which shows the model without any controls, follows this pattern quite closely and keeps going up fast. This means that the model is correct when it comes to how TB spreads without any controls. The green line, which shows the model with controls (such treatment and distancing), goes up considerably more slowly and cuts down on the number of TB cases. The space between the green and orange lines clearly stops at about 700 cases in 2025. This slower rise shows that interventions are effective and how much control approaches may change things. Over time, timely measures can considerably reduce TB cases, as seen in the figure.

Fig 6. Model Fit to Real Data (2010-2025) of total TB cases assessed with and without control measures.

Fig 6

8. Results and discussions

8.1. Numerical technique

Three numerical methods are used to approximate the governing system: the fourth-order Runge–Kutta method for deterministic simulation, finite difference schemes for spatial discretisation, and implicit solvers for stiff regime stability. Step-size refinement and technique comparisons proved the accuracy and consistency of the calculated trajectories, preserving the epidemic dynamics’ qualitative behaviour across computing methodologies.

8.2 Comparisons for infectious and treatment population trajectories using control strategies

The long-term effects of control strategies on infected and treated populations over a 25-year period are shown in Fig 7 (Fig 7A and Fig 7B (S1 Fig)). When compared to the uncontrolled situation, a significant decrease in infection levels is seen under controlled conditions, indicating the efficacy of the implemented interventions. By preventing the spread of disease, control techniques significantly reduce the strain on treatment resources, as seen by a corresponding drop in treatment demand.

Fig 7. Comparison of infectious and treated population trajectories under controls.

Fig 7

Fig 8 (Fig 8A and Fig 8B (S1 Fig)) illustrate how the basic reproduction number (R0) changes in response to variations in the treatment parameter τ and the transmission rate β within the SEITR model, where values greater than one suggest disease persistence and values less than one indicate elimination. An inverse and nonlinear relationship is evident between R0 and τ, with elevated reproduction levels present at low τ values, which quickly decline toward near-zero as τ increases, signifying improved epidemic management. A direct and roughly linear relationship is observed between R0 and β, where an increase in transmission intensity results in a proportional rise in the reproduction number. When β reaches a certain point, the epidemic threshold is crossed, and continuous transmission is expected. These findings underscore that both efficient transmission reduction and the improvement of treatment-related processes are essential for reducing R0 below the critical threshold and achieving disease control.

Fig 8. Sensitivity of the basic reproduction number (R0) with respect to parameters τ and β.

Fig 8

8.3. Dynamics of control strategies

The control panel profile is used to show how important intervention parameters change and work together in the proposed modeling structure. We examine the impact of control methods on system behaviour and their efficacy in infection management by demonstrating their functionality. The model uses the following controls, which are shown in the graphs below:

Fig 9 illustrate the most effective time-dependent methods for epidemic control. They demonstrate prevention (u1, labeled as Distancing) and treatment (u2, labeled as therapy) efforts over a 200-day period. The graphs demonstrate that an effective control technique necessitates both high levels of distance and therapy at the beginning. For the first 60 days, distance efforts (u1) should be held at 0.4 and then rapidly reduced. This means that preventative efforts should be prioritized from the start. In contrast, treatment efforts (u2) are maintained at a higher level of 0.7 for a longer period, typically 100 days, before decreasing progressively. This suggests a phased approach in which early and robust prevention measures are critical, followed by continuous therapeutic intervention, which is gradually reduced, to effectively control the epidemic, as modeled by an SEITR that is gradually reduced, compartmental system. The weight parameters (a1, a2, a3, a4, a5) determine the relative relevance of various objectives in the control issue. For example, a greater emphasis on therapy interventions may result. By comparing the control techniques in the three figures (Fig 9A, Fig 9B and Fig 9C (S1 Fig)), we can understand how changes in the weight parameters influence the best control options.

Fig 9. Different control panels (A), (B), and (C) obtained using different weight parameters.

Fig 9

Fig 10 (S1 Fig) illustrates the results of a mathematical model for tuberculosis (TB), which integrates various disease control measures over time. This model examines four scenarios for preventing the spread of TB using two types of interventions: distance control (u1) and treatment control (u2). The green dashed line (u1=0,u2=0) represents a scenario with no control measures implemented (i.e., neither distancing nor treatment). In this case, the number of infected individuals consistently increases over time, demonstrating the worst-case scenario in which the disease spreads uncontrollably. The red dashed line (u1≠0,u2=0) indicates a scenario in which only distance control is applied, without any treatment control. In this case, the number of infections decreases below the level shown by the green line, but not as significantly as in other scenarios. While distancing helps slow the spread of the disease, it cannot completely contain the outbreak.

Fig 10. The density of total infected individuals analyzed with and without control measures.

Fig 10

The blue dotted line (u1=0,u2≠0) indicates that only treatment control is implemented, while no distancing control is applied. In this scenario, the number of infections initially increases; however, over time, treatment significantly reduces the infected population. This method proves to be more effective than relying solely on distancing measures. On the other hand, the purple line with circles (u1≠0,u2≠0) shows that both distancing and treatment controls are applied simultaneously. This combined approach results in the best outcomes, as infections are reduced rapidly and sustainably. This demonstrates that the most effective way to control tuberculosis (TB) is by combining both distancing and treatment strategies.

9. Cost-effectiveness evaluation

To enhance policy relevance, an Incremental Cost-Effectiveness Ratio (ICER) framework is introduced. The total intervention cost over the time horizon T is defined as

C(u1,u2)=∫0T(a42u12+a52u22)dt.

The effectiveness measure is defined as the total infections averted

E=∫0T(Ino control−Icontrol)dt.

The ICER is computed as

ICER=Cstrategy−CbaselineEstrategy−Ebaseline.

According to the economic assessment in S3 Table, under the baseline scenario, no funds are allotted, hence no illnesses are avoided. Distancing alone results in a moderate decrease in TB cases, but the incremental cost per case is significantly higher than with treatment-based interventions. While the combination control approach yields the highest epidemiological benefit at a higher total cost, the treatment-only strategy is linked to the lowest cost per case avoided. From a Bangladesh perspective, the treatment-focused intervention is economically preferable if it costs less per TB case prevented, whereas the dual strategy may be justified when maximizing disease reduction is prioritized over cost minimization.

10. Conclusions

A numerical SEITR model is developed to investigate tuberculosis transmission and assess the effectiveness of distancing and treatment controls. The influence of key transmission and progression parameters on the basic reproduction number (R0) is examined to identify factors that sustain disease spread, and model stability has been analytically verified. Furthermore, optimal control theory is applied to evaluate strategies for reducing infection levels and to interpret the epidemiological implications of the results.

  • The SEITR model is analyzed analytically and numerically. And it is established that the disease-free equilibrium is both locally and globally asymptotically stable whenever R0 < 1, while a unique endemic equilibrium is present and globally stable when R0 > 1.

  • Evidence shows that reducing the effective contact rate (β) through distancing measures substantially inhibits transmission of new infections.

  • Better treatment has been shown to speed up recovery and lower the death rate among people who are infected.

  • The simultaneous implementation of distancing (u1) and treatment (u2) strategies has proven more effective than methods relying on a single intervention.

  • It has been recognized that the timely and ongoing implementation of control measures is crucial for maintaining disease stability.

  • The model’s alignment with actual data has been validated, reinforcing its importance for public health strategy development.

  • The cost-effectiveness analysis showed that dual control has a higher total implementation cost, but it has the lowest additional cost per infection avoided. Consequently, the integrated control technique is acknowledged as economically superior under reasonable assumptions.

It is clear that the best way to control tuberculosis is to use both behavioural and medicinal treatments together. The models’ outcomes emphasize the significance of ongoing public awareness, access to health care, and adherence to treatment. Mathematical modeling has demonstrated efficacy as a decision-support instrument for optimizing intervention design and resource allocation. Optimal control simulations demonstrated that the simultaneous implementation of distance and treatment strategies yielded the greatest and most significant reduction in infection prevalence over time. Validation of the model using tuberculosis data from 2010 to 2025 demonstrated robust predictive consistency, and projection analysis indicated that the continued application of dual-control methods might substantially reduce the TB burden by 2030.

The model does not consider treatment failure or recurrence because this study assumes treatment is entirely effective. Therefore, some characteristics of true TB progression and control may be missed. The current SEITR optimum control model requires homogeneous mixing, consistent intervention adherence, and deterministic cost-effectiveness evaluation. It also lacks population heterogeneity, random variability, and uncertainty treatment, which may limit its real-world usefulness. For realism and policy relevance, treatment failure and relapse, varied contact patterns, stochastic dynamics, and larger economic evaluations will be integrated in future research.

Supporting information

S1 Data. Annual TB data used in this study.

(XLSX)

pgph.0005875.s001.xlsx (9.2KB, xlsx)
S1 Fig. Model flow diagram and supporting figure.

(DOCX)

pgph.0005875.s002.docx (1.5MB, docx)
S1 Table. Indices of sensitivity of R0 to some model parameters.

(PDF)

pgph.0005875.s003.pdf (235.8KB, pdf)
S2 Table. Global sensitivity results based on SRC and PRCC (N = 1000 samples).

(PDF)

pgph.0005875.s004.pdf (217.1KB, pdf)
S3 Table. Cost-effectiveness analysis of TB control strategies.

(PDF)

pgph.0005875.s005.pdf (109.1KB, pdf)
S1 Appendix. Overview of model parameters.

(PDF)

pgph.0005875.s006.pdf (349.8KB, pdf)
S1 Text. Annual Tuberculosis totals from 2010 to 2025.

(PDF)

pgph.0005875.s007.pdf (145.8KB, pdf)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This study was financially supported by the University Grants Commission (UGC) of Bangladesh (https://ugc.gov.bd) in the form of a grant (PhD Fellowship 2022-2023, Serial no. 44) received by MAS. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Tran HM, Tsai F-J, Lee Y-L, Chang J-H, Chang L-T, Chang T-Y, et al. The impact of air pollution on respiratory diseases in an era of climate change: A review of the current evidence. Sci Total Environ. 2023;898:166340. doi: 10.1016/j.scitotenv.2023.166340 [DOI] [PubMed] [Google Scholar]
  • 2.Jacob JT, Mehta AK, Leonard MK. Acute forms of tuberculosis in adults. Am J Med. 2009;122(1):12–7. doi: 10.1016/j.amjmed.2008.09.018 [DOI] [PubMed] [Google Scholar]
  • 3.Schwalb A, Dodd PJ, Rickman HM, Ugarte-Gil CA, Horton KC, Houben RMGJ. Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study. PLoS Med. 2026;23(2):e1004920. doi: 10.1371/journal.pmed.1004920 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Olayiwola MO, Oluwafemi EA. Hereditary and antimicrobial factor shaping extracellular bacteria dynamics in an in-host mathematical model of tuberculosis for disease control. Tuberculosis (Edinb). 2025;154:102668. doi: 10.1016/j.tube.2025.102668 [DOI] [PubMed] [Google Scholar]
  • 5.Olaniyi S, Abimbade SF, Chuma FM, Adepoju OA, Falowo OD. A fractional-order tuberculosis model with efficient and cost-effective optimal control interventions. Decision Analytics Journal. 2023;8:100324. doi: 10.1016/j.dajour.2023.100324 [DOI] [Google Scholar]
  • 6.Trauer JM, Denholm JT, McBryde ES. Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific. J Theor Biol. 2014;358:74–84. doi: 10.1016/j.jtbi.2014.05.023 [DOI] [PubMed] [Google Scholar]
  • 7.Petropoulos F, Apiletti D, Assimakopoulos V, Ziel F. Forecasting: Theory and practice. International Journal of Forecasting. 2022;38(3):76–85. [Google Scholar]
  • 8.Li Y, Liu X, Yuan Y, Li J, Wang L. Global analysis of tuberculosis dynamical model and optimal control strategies based on case data in the United States. Applied Mathematics and Computation. 2022;422:126983. doi: 10.1016/j.amc.2022.126983 [DOI] [Google Scholar]
  • 9.Heitkamp P, Chijioke-Akaniro O, Pai M. From dependence to self-reliance: The future of the global tuberculosis response. PLoS Med. 2025;22(11):e1004824. doi: 10.1371/journal.pmed.1004824 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhang W-D, Zu Z-H, Xu Q, Xu Z-J, Liu J-J, Zheng T. Optimized strategy for the control and prevention of newly emerging influenza revealed by the spread dynamics model. PLoS One. 2014;9(1):e84694. doi: 10.1371/journal.pone.0084694 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fonseca LL, Böttcher L, Mehrad B, Laubenbacher RC. Optimal control of agent-based models via surrogate modeling. PLoS Comput Biol. 2025;21(1):e1012138. doi: 10.1371/journal.pcbi.1012138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Alabdala AT, Adel Y, Adel W. Optimal control strategies for infectious disease management: Integrating differential game theory with the SEIR model. Partial Differential Equations in Applied Mathematics. 2024;12:100943. doi: 10.1016/j.padiff.2024.100943 [DOI] [Google Scholar]
  • 13.Wu P, Lau EHY, Cowling BJ, Leung C-C, Tam C-M, Leung GM. The transmission dynamics of tuberculosis in a recently developed Chinese city. PLoS One. 2010;5(5):e10468. doi: 10.1371/journal.pone.0010468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Boonpatcharanon S, Heffernan JM, Jankowski H. Estimating the basic reproduction number at the beginning of an outbreak. PLoS One. 2022;17(6):e0269306. doi: 10.1371/journal.pone.0269306 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fatmawati CCW, Alqahtani RT, Alfiniyah C, Herdicho FF, Tasmi. A Pontryagin’s maximum principle and optimal control model with cost-effectiveness analysis of the COVID-19 epidemic. Decision Analytics Journal. 2023;8:100273. doi: 10.1016/j.dajour.2023.100273 [DOI] [Google Scholar]
  • 16.Salek MA, Nayeem J, Yesmin R, Biswas MHA, Kabir MH. Optimal control strategies for infectious diseases: a numerical simulation approach. Mathematical Modelling and Numerical Simulation with Applications. 2026;6(1). doi: 10.53391/2791-8564.1023 [DOI] [Google Scholar]
  • 17.Cortés-Caicedo B, Guzmán-Henao JA, Montoya OD, Grisales-Noreña LF, Bolaños RI. Optimized conductor selection and phase balancing in unbalanced distribution networks: Economic optimization via the vortex search algorithm. Results in Control and Optimization. 2025;20:100578. doi: 10.1016/j.rico.2025.100578 [DOI] [Google Scholar]
  • 18.Wang Y, Cao D, Liu G. Application of antimicrobial drugs in Mycobacterium tuberculosis and research progress. Microb Pathog. 2025;206:107794. doi: 10.1016/j.micpath.2025.107794 [DOI] [PubMed] [Google Scholar]
  • 19.Edward S, Shaban N. Deterministic compartmental model for optimal control strategies of Giardiasis infection with saturating incidence and environmental dynamics. Healthcare Analytics. 2025;7:100383. doi: 10.1016/j.health.2025.100383 [DOI] [Google Scholar]
  • 20.Kim S, de Los Reyes V AA, Jung E. Country-specific intervention strategies for top three TB burden countries using mathematical model. PLoS One. 2020;15(4):e0230964. doi: 10.1371/journal.pone.0230964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rahman SMS, Mondal R, Santa S, Anisujjaman Md, Ferdushi KF, Haque MdR. Mathematical analysis of the SEIRD model for the spread of tuberculosis in Bangladesh. Int j adv appl sci. 2025;12(12):229–36. doi: 10.21833/ijaas.2025.12.020 [DOI] [Google Scholar]
  • 22.Rodrigues P, Silva CJ, Torres DFM. Cost-effectiveness analysis of optimal control measures for tuberculosis. Bull Math Biol. 2014;76(10):2627–45. doi: 10.1007/s11538-014-0028-6 [DOI] [PubMed] [Google Scholar]
  • 23.Feng Z, Towers S, Yang Y. Modeling the effects of vaccination and treatment on pandemic influenza. AAPS J. 2011;13(3):427–37. doi: 10.1208/s12248-011-9284-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Niksirat MA, Mehri B. On the existence of positive solution for second-order multi-points boundary value problems. Journal of Computational and Applied Mathematics. 2006;193(1):269–76. doi: 10.1016/j.cam.2005.06.006 [DOI] [Google Scholar]
  • 25.Khan MA, DarAssi MH, Ahmad I, Seyam NM, Alzahrani E. Modeling the Dynamics of Tuberculosis with Vaccination, Treatment, and Environmental Impact: Fractional Order Modeling. CMES. 2024;141(2):1365–94. doi: 10.32604/cmes.2024.053681 [DOI] [Google Scholar]
  • 26.Nayeem J, Podder CN, Salek MA. Sensitivity Analysis And Impact Of An Imperfect Vaccine Of Two Strains Of Hepatitis B Virus Infection. J Biol Syst. 2023;31(02):437–58. doi: 10.1142/s0218339023500158 [DOI] [Google Scholar]
  • 27.Alamo T, G Reina D, Millán Gata P, Preciado VM, Giordano G. Data-driven methods for present and future pandemics: Monitoring, modelling and managing. Annu Rev Control. 2021;52:448–64. doi: 10.1016/j.arcontrol.2021.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pandey A, Bhadauria AS, Verma VS. Impact of awareness and time-delayed saturated treatment on the transmission of infectious diseases. Results in Control and Optimization. 2024;17:100463. doi: 10.1016/j.rico.2024.100463 [DOI] [Google Scholar]
  • 29.Nayeem J, Sultana I. Mathematical Analysis of the Transmission Dynamics of Tuberculosis. AJCM. 2019;09(03):158–73. doi: 10.4236/ajcm.2019.93012 [DOI] [Google Scholar]
  • 30.Zhang H, Zhao A, Liu Z, Meng L, Zhang L, Li P. Evaluating the elastic wave speed in heterogeneous materials and structures: A concurrent multiscale modeling approach. Composite Structures. 2025;365:119193. doi: 10.1016/j.compstruct.2025.119193 [DOI] [Google Scholar]
  • 31.Kamgang JC, Sallet G. Global asymptotic stability for the disease free equilibrium for epidemiological models. Comptes Rendus Mathématique. 2005;341(7):433–8. doi: 10.1016/j.crma.2005.07.015 [DOI] [Google Scholar]
  • 32.www.who.int/teams/global-tuberculosis-programme/data and https://data.worldbank.org/indicator/SH.TBS.INCD
  • 33.National TB Control Program. Yearly distribution of TB cases in Bangladesh from 2010–2024. Shyamoli, Dhaka: National TB Control Project Hospital. 2024. [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005875.r001

Decision Letter 0

Somayeh Hessam

2 Feb 2026

PGPH-D-26-00093

Dynamical Behavior Analysis of 2-control Strategies on Tuberculosis Model

PLOS Global Public Health

Dear Dr. Nayeem,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 19 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Somayeh Hessam

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please note that PLOS Global Public Health has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/globalpublichealth/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB.

3. Please provide a detailed online Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

a) State the initials, alongside each funding source, of each author to receive each grant. For example: “This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM).”

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

For more information, please go to our submission guidelines:

https://journals.plos.org/globalpublichealth/s/submission-guidelines#loc-financial-disclosure-statement

4. Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well.

5. Please update your online Competing Interests statement. If you have no competing interests to declare, please state: “The authors have declared that no competing interests exist.”

6. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.

At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/globalpublichealth/s/recommended-repositories.

7. We note that you may not have used the PLOS LaTeX template. This is not required, but please be sure that you are familiar with our LaTeX guidelines to help reduce the chance of delay due to typesetting errors. Our guidelines can be found here: https://journals.plos.org/digitalhealth/s/latex

8. Please ensure that you have provided a single, cohesive .tex file for your LaTeX submission. As stated in the PLOS template, your references should be included in your .tex file (not submitted separately as .bib or .bbl). Please also ensure that you are making any formatting changes to both your .tex file and the PDF of your manuscript. If you have any questions, please contact Latex@plos.org. You can find our LaTeX guidelines here: https://journals.plos.org/digitalhealth/s/latex

9. Please provide separate main figure files in .tif or .eps format only and ensure that all files are under our size limit of 10MB. You may leave the embedded figures in the manuscript.

For more information about how to convert your figure files please see our guidelines: https://journals.plos.org/globalpublichealth/s/figures

10. We notice that your supplementary material (Appendix) is included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript before or after the references list.

11. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.-->

Reviewer #1: Partly

Reviewer #2: Partly

Reviewer #3: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Recommendation 1: The modeling approach is fundamentally sound and relevant to TB control (a major public health issue), but the manuscript needs to address transparency (data sources, parameter justification) and clarify some methodological assumptions (e.g. definition of Reproduction number) before it can be accepted.

Recommendation 2: The sensitivity analysis methods (Pearson, PRCC) are suitable but need more rigor in reporting (sample details, uncertainty). The data-fitting procedure requires complete description (data source, fitting algorithm, goodness-of-fit). The authors should include more quantitative statistical assessment of their model fit and uncertainty in parameter effects.

Recommendation 3: The authors should provide a Data Availability Statement with actual access information (URL, DOI, or supplementary files) for the epidemiological data and any other material used. At the end of the file, an editorial link points to the Bangladesh NTP Annual Report 2022, which presumably provided TB case counts, but this is not an open dataset citation. Without accessible data, readers cannot reproduce or verify the results.

Recommendation 4: The writing requires major language editing. Grammatical issues and awkward phrasing occur repeatedly. Several citations are incomplete (marked as “[?]”). These issues hinder readability. The manuscript would benefit from careful editing by a fluent English speaker. With editing, the intellectual content is conveyable, but in its current state the language detracts from clarity.

Reviewer #2: This manuscript presents a mathematical modeling study on tuberculosis transmission using an SEITR framework incorporating distancing and treatment control strategies. The authors apply optimal control theory, stability analysis, sensitivity analysis, and data fitting to assess the impact of interventions. The topic is relevant to public health and epidemiological modeling, and the integration of control theory with real data is a valuable contribution. Overall, the study demonstrates potential scientific merit; however, several important issues should be addressed to improve the quality, clarity, and reliability of the work.

Major Strengths

The manuscript develops a structured SEITR model that includes exposed and treated compartments, allowing for a more realistic representation of tuberculosis dynamics.

The application of Pontryagin’s Maximum Principle to determine optimal intervention strategies is appropriate and well motivated.

The use of sensitivity analysis, including Pearson correlation and PRCC, strengthens the interpretation of key parameters.

Incorporation of real tuberculosis data from Bangladesh and curve fitting enhances the practical relevance of the study.

The findings highlight the importance of combined distancing and treatment strategies, which is relevant for policy planning.

Major Concerns

Language and Presentation

The manuscript contains numerous grammatical errors, awkward phrasing, and unclear sentences that affect readability. Several sections require substantial English language editing. Professional proofreading is strongly recommended to improve clarity and coherence.

Incomplete and Missing Citations

Many references in the text are marked with “[?]”, indicating missing citations. These must be replaced with appropriate and verifiable references. Failure to do so weakens the scientific credibility of the manuscript.

Reference Quality and Formatting

Several references appear incomplete, inconsistently formatted, or potentially inaccurate. All references should be verified and formatted according to journal guidelines. The authors should ensure that all cited sources are reliable and accessible.

Mathematical Notation and Consistency

Some notations are used ambiguously, particularly the symbol λ, which represents both the force of infection and adjoint variables. This may confuse readers. The notation should be revised for clarity. In addition, some derivations in the optimal control section are not sufficiently detailed and require clearer explanation.

Data Availability and Reproducibility

The Data Availability Statement is insufficient. PLOS requires full access to underlying data and, where applicable, code. The authors should provide the dataset in an accessible repository and include links. Details on parameter estimation and model fitting procedures should also be expanded.

Model Validation

While curve fitting is presented, quantitative goodness-of-fit measures (e.g., RMSE, R², confidence intervals) are not provided. Including these metrics would strengthen the validation of the model.

Overstatement of Novelty

The novelty section contains strong claims that are not fully supported by the analysis. The authors should moderate these statements and clearly specify how their approach differs from and extends existing studies.

Figures and Visualization

Some figures lack sufficient resolution, clear legends, and readable labels. All figures should be revised to meet publication standards and to improve interpretability.

Ethical and Data Source Clarification

The manuscript should clearly state whether ethical approval was required for the use of hospital data and how patient confidentiality was ensured, even if the data are aggregated.

Minor Concerns

Several typographical errors and formatting inconsistencies are present throughout the manuscript.

Some sections are repetitive, particularly in the Introduction and Discussion.

Units and parameter descriptions in the appendix should be clarified and consistently presented.

The structure of some tables can be improved for better readability.

Suggestions for Improvement

Revise the entire manuscript for language quality and clarity.

Replace all missing citations and verify references.

Improve mathematical notation and provide clearer derivations.

Expand the methodology for parameter estimation and numerical implementation.

Provide full data and code access in line with PLOS policies.

Include quantitative validation metrics.

Revise figures and tables for better presentation.

Reframe the novelty claims in a more balanced manner.

Conclusion

The manuscript addresses an important topic and combines mathematical modeling with real data and optimal control analysis. With substantial revision focusing on language quality, citation completeness, data transparency, mathematical clarity, and methodological rigor, the study has the potential to make a meaningful contribution to tuberculosis control research. At present, major revisions are necessary before the manuscript can be considered for publication.

Reviewer #3: PLOS Global Public Health (PGPH-D-26-00093)

Reviewer’s Comments

The authors studied ‘Dynamical Behavior Analysis of 2-control Strategies on Tuberculosis Model. The authors must be commended for carrying out this research. As the paper is, technically correct formulation of the SEITR system, Standard application of Pontryagin’s Maximum Principle, Inclusion of sensitivity analysis and data fitting and clear policy motivation (treatment and distancing synergy). However, authors need to address the following suggestions to improve the manuscript:

Comment 1: Abstract

Please consider/incorporate the followings points in the abstract

i. aim/ objectives

ii. Methods applied

iii. Results/ Findings

iv. Recommendations to policymakers

Comment 2: Introduction

Please consider/incorporate the following points in the introduction.

i. Significance of the research

ii. Please clearly indicate in a summarized form your observations about the related literature reviewed as compared to your research.

Comment 3: Research gap and main contribution

At the ending section of the introduction:

i. Authors should clearly state the research gap in the manuscript.

ii. SEIR/SEITR TB models with: treatment control, distancing or awareness control, PMP-based optimal control, sensitivity analysis have been extensively studied (including several papers already cited). Authors should compare their research with the existing literature and state what exactly is new in their research (main contribution) compared to existing studies.

iii. The claimed novelty which comprises “composite analytical methodology integrating control-oriented stability decomposition with normalized forward sensitivity indexing” is not clearly demonstrated mathematically. Authors should check that.

Comment 4: Stability analysis

The stability analysis must be improved. Authors analyzed only DFE stability. Authors should consider Endemic equilibrium (EE) existence, Local or global stability of EE and Backward bifurcation analysis. Since TB models, normally exhibit backward bifurcation and highly relevant.

Comment 5: Sensitivity analysis

Authors conducted so many sensitivity plots, with little insight. Parameter ranges are not clearly justified and some interpretations are inconsistent (e.g., γ showing weak PRCC but strong analytical sensitivity). Authors should correct that.

Comment 6: Grammatical Errors

There are some grammatical errors in the manuscript. For instance

1. “Pontryagain’s” → Pontryagin’s

2. Repetitive phrases (“It is noted that…”, “It is observed that…”) and

3. Overly long descriptive captions instead of analytical discussion

Comment 7: Inconsistencies in Notations

1. The authors used \lambda for both force of infection and adjoint derivative,

2. Parameters appear in equations but are not always defined immediately

3. Table 1 includes parameter \eta which does not appear in the model

Authors should correct that.

Comment 9: In Text-Reference

A lot of in-text references are missing in the manuscript. Authors should correct that.

Comment 10: Conclusion

State the limitations and future work in this section.

Comment 11: Cost-effectiveness analysis

Cost-effectiveness analysis can be added to the control model to improve the manuscript.

Remarks: Minor Revision Required

Thank you

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: Yes: Uzair Ahmed

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

-->Figure Resubmissions:

-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

Attachment

Submitted filename: Review Comments for PLOS HEALTH REVIEW.docx

pgph.0005875.s008.docx (18.2KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005875.r003

Decision Letter 1

Somayeh Hessam

12 Apr 2026

PGPH-D-26-00093R1

Dynamical Behavior Analysis of 2-control Strategies on Tuberculosis Model

PLOS Global Public Health

Dear Dr. Nayeem,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 12 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Somayeh Hessam

Academic Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

-->2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.-->

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #2: The authors have adequately addressed all comments raised in the previous round of review. The revisions have significantly improved the clarity, methodological rigor, and overall presentation of the manuscript.

The study presents a well-structured and technically sound analysis of the dynamical behavior of tuberculosis transmission under two control strategies. The modeling framework is appropriate, and the assumptions are clearly stated and justified. The statistical and mathematical analyses appear to be conducted rigorously, and the results are presented in a coherent and interpretable manner.

Importantly, the conclusions are well supported by the data and align with the objectives of the study. The authors have also ensured compliance with data availability requirements, which enhances transparency and reproducibility.

The manuscript is clearly written in standard English, with improved organization and readability compared to the previous version. Any minor typographical or grammatical issues noted earlier have been appropriately corrected.

Overall, the manuscript now meets the publication criteria of PLOS Global Public Health and is suitable for publication.

Reviewer #3: Dear Editor

PLOS Global Public Health(PGPH-D-26-00093R1)

Reviewer’s Comments

The authors studied ‘Dynamical Behavior Analysis of 2-control Strategies on Tuberculosis Model. I have checked the revised version of the manuscript according to the comments given. The authors have revised the manuscript according to the comments. I suggest that the manuscript can be accepted for publication PLOS Global Public Health after this minor suggestion. However, authors need to address the suggestion below to improve the manuscript:

Comment on main Contribution

The main contributions must not be stated as questions. Authors should correct that. Authors should be:

1. Specific: Focus on what is new (novel theory), the method, or data.

2. Employ Active Verbs: Begin them with phrases such as "We propose," "We discover," "We develop," or "We demonstrate" etc

3. The introduction should state the questions you asked, while the contribution section

(or conclusion) should state the answers you found.

Remarks: Accept

Thank you

Reviewer #4: Interesting study, here are my recommendations to improve the manuscript:

- Authors need to conform to international guidelines of scientific writing. Sentences like "doctors typically diagnose..." can be better written with "healthcare professionals diagnose..."

- The introduction section has information about the basics of tuberculosis and models design that are not necessarily important to the study. Can revise and shorten. See comment above too.

- In fact, it would be beneficial if you provide details about the current TB control strategy in Bangladesh and some background epidemiologic data about TB in Bangladesh (the country of interest) the introduction.

- tuberculin skin test is use to diagnose TB "infection"- clarify this to readers

- I assume that the first control strategy "treatment" involves treatment of active TB disease, not latent infection.

- Not sure if authors accounted for failure of TB treatment in the model?

- What is the prevalence of MDR-TB in Bangladesh and was this accounted for in the transmission model and cost-effectiveness model?

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #2: Yes: ABDULRAZAK MOHAMED AHMED QUDDE

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

-->Figure Resubmissions:

-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005875.r005

Decision Letter 2

Somayeh Hessam

26 Apr 2026

Dynamical Behavior Analysis of 2-control Strategies on Tuberculosis Model

PGPH-D-26-00093R2

Dear Dr. Nayeem,

We are pleased to inform you that your manuscript 'Dynamical Behavior Analysis of 2-control Strategies on Tuberculosis Model' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Somayeh Hessam

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Annual TB data used in this study.

    (XLSX)

    pgph.0005875.s001.xlsx (9.2KB, xlsx)
    S1 Fig. Model flow diagram and supporting figure.

    (DOCX)

    pgph.0005875.s002.docx (1.5MB, docx)
    S1 Table. Indices of sensitivity of R0 to some model parameters.

    (PDF)

    pgph.0005875.s003.pdf (235.8KB, pdf)
    S2 Table. Global sensitivity results based on SRC and PRCC (N = 1000 samples).

    (PDF)

    pgph.0005875.s004.pdf (217.1KB, pdf)
    S3 Table. Cost-effectiveness analysis of TB control strategies.

    (PDF)

    pgph.0005875.s005.pdf (109.1KB, pdf)
    S1 Appendix. Overview of model parameters.

    (PDF)

    pgph.0005875.s006.pdf (349.8KB, pdf)
    S1 Text. Annual Tuberculosis totals from 2010 to 2025.

    (PDF)

    pgph.0005875.s007.pdf (145.8KB, pdf)
    Attachment

    Submitted filename: Review Comments for PLOS HEALTH REVIEW.docx

    pgph.0005875.s008.docx (18.2KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pgph.0005875.s010.docx (37KB, docx)
    Attachment

    Submitted filename: Response to Reviewers_2nd.docx

    pgph.0005875.s011.docx (31KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES